Kane Biotech (KNE) Stock Price, News & Analysis

Company Overview

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections. It offers revyve, an antimicrobial wound gel; and shampoos, shampoo bars, and scalp detoxifiers under the DermaKB brand. The company is also developing coactiv+ Antimicrobial Surgical Hydrogel for use in surgical/acute wounds; coactiv+ Antimicrobial Wound Rinse for use in acute and chronic wounds; coactiv+ Antimicrobial Wound Gel Spray for use in acute, chronic wounds, and first and second degree burns; and DispersinB Hydrogel for prosthetic joint infection. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.

Key Stats

• Today's Range: C$0.11 to C$0.11
• 50-Day Range: C$0.10 to C$0.14
• 52-Week Range: C$0.06 to C$0.17
• Volume: 12,000 shs
• Average Volume: 125,655 shs
• Market Capitalization: C$14.58 million
• P/E Ratio: N/A
• Dividend Yield: 3.08%
• Price Target: N/A
• Consensus Rating: N/A

KNE Stock Analysis - Frequently Asked Questions

How have KNE shares performed this year?

Kane Biotech's stock was trading at C$0.08 at the start of the year. Since then, KNE shares have increased by 37.5% and is now trading at C$0.11.
View the best growth stocks for 2024 here.

How were Kane Biotech's earnings last quarter?

Kane Biotech Inc. (CVE:KNE) announced its quarterly earnings data on Thursday, August, 29th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.62 million for the quarter.

How do I buy shares of Kane Biotech?

Shares of KNE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Kane Biotech own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Kane Biotech investors own include Mason Resources (LLG), Datametrex AI (DM) and Allstar Health Brands (ALST).

Company Calendar

• Last Earnings: 8/29/2024
• Today: 11/21/2024
• Next Earnings (Estimated): 11/26/2024

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: CVE:KNE
• CUSIP: N/A
• CIK: N/A
• Web: www.kanebiotech.com
• Phone: +1-204-4531301
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-5,480,000.00
• Net Margins: 637.45%
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -58.43%

Debt

• Debt-to-Equity Ratio: 1,164.24
• Current Ratio: 0.82
• Quick Ratio: 0.39

Sales & Book Value

• Annual Sales: C$2.74 million
• Price / Sales: 5.32
• Cash Flow: C$0.01 per share
• Price / Cash Flow: 8.50
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 132,510,000
• Free Float: N/A
• Market Cap: C$14.58 million
• Optionable: Not Optionable
• Beta: 0.52